9.
Encounter for screening, unspecified Z13. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z13. 9 became effective on October 1, 2021.
There are three codes for COVID-19 testing: 87635 is designed to detect the COVID-19 virus and effective March 13, 2020, and 86328 and 86769 will be used to identify the presence of antibodies to the COVID-19 virus and are effective April 10, 2020.
Code Z21 is used for patients who are asymptomatic, meaning they are HIV positive but have never had an HIV-related condition. Once that patient experiences an HIV-related condition, the Z21 code is no longer appropriate.
Question: An insurer asked us to use wellness codes 99381 to 99397 for biometric screening. However, as per the CPT ® guide lines, 99401 or 99402 would be more appropriate.
Z12. 11: Encounter for screening for malignant neoplasm of the colon.
Currently, there are no specific ICD-10 codes to use when billing for services related to COVID-19. The CDC has provided the following coding guidelines for COVID-19. B97. 29, Other coronavirus as the cause of diseases classified elsewhere.
Feb. 21, 2022: Addition of code 87913 to report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) mutation identification in targeted region(s).
For individuals with MIS and COVID-19, assign code U07. 1, COVID-19, as the principal/first-listed diagnosis and assign code M35. 81 as an additional diagnosis. If MIS develops as a result of a previous COVID-19 infection, assign codes M35.
Following ICD-10 guidelines, if a patient has or has had an HIV related condition, use B20 AIDS. If the patient has a positive HIV status, without symptoms or related conditions, use Z21.
For example, Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is the correct code to use when you are ordering a routine mammogram for a patient. However, coders are coming across many routine mammogram orders that use Z12. 39 (Encounter for other screening for malignant neoplasm of breast).
Human immunodeficiency virus [HIV] disease B20 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM B20 became effective on October 1, 2021.